VERA.NASDAQVera Therapeutics, INC

Form 4: Vera Therapeutics Director Beth C. Seidenberg Sells Shares

Sentiment:

SEC Form 4

📋All filings for Vera Therapeutics, INC
🔒Login to Follow

Director Beth C. Seidenberg sold shares of Vera Therapeutics (VERA) on September 18 and 19, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Beth C. Seidenberg, a director of Vera Therapeutics, sold Class A Common Stock on September 18 and 19, 2024.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on June 19, 2024.
  • On September 18, 2024, 1,177 shares were sold at a weighted average price of $42.0119, with prices ranging from $42.00 to $42.07.
  • An additional 13,823 shares were sold on September 19, 2024, at a weighted average price of $42.3058, with prices ranging from $42.00 to $42.79.
  • Following these transactions, Seidenberg directly owns 146,553 shares and indirectly owns 4,012 shares through the Samuel B. Seidenberg Irrevocable Trust.
  • Seidenberg also has indirect beneficial ownership due to being one of the managing members of KPCB XVI Associates, LLC.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating stock sales by a company director. The sales were conducted under a pre-arranged trading plan, suggesting no immediate negative implications. The sentiment is neutral.

Industry Context

Sales by company directors are a normal part of business. It is important to note that the sales were executed under a pre-arranged 10b5-1 trading plan, which is a common practice to avoid accusations of insider trading.

Key Dates

DateDescription
July 1, 2013Date the Samuel B. Seidenberg Irrevocable Trust was established.
April 10, 2024KPCB XVI and XVI Founders made a pro-rata in-kind distribution of 750,000 Shares.
April 10, 2024The Reporting Person received an aggregate of 161,553 Shares as part of a pro-rata in-kind distribution without consideration from KPCB XVI, XVI Founders and their managing member, XVI Associates.
April 12, 2024The Reporting Person received an aggregate of 161,553 Shares as part of a pro-rata in-kind distribution without consideration from KPCB XVI, XVI Founders and their managing member, XVI Associates.
June 5, 2024KPCB XVI and XVI Founders made an additional pro-rata in-kind distribution of 1,199,295 Shares.
June 5, 2024The Reporting Person received an aggregate of 5,488 Shares were received as part of a pro-rata in-kind distribution without consideration from XVI Associates, the managing member of KPCB XVI and XVI Founders.
June 13, 2024The Reporting Person received an aggregate of 161,553 Shares as part of a pro-rata in-kind distribution without consideration from KPCB XVI, XVI Founders and their managing member, XVI Associates.
June 19, 2024Date the Reporting Person adopted a Rule 10b5-1 trading plan.
September 18, 2024Beth C. Seidenberg sold 1,177 shares of Class A Common Stock.
September 19, 2024Beth C. Seidenberg sold 13,823 shares of Class A Common Stock.
September 20, 2024Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.